Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Chondrosarcoma, Mesenchymal × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 7 Leiomyosarcoma 3 Sarcoma, Synovial 2 Sarcoma, Alveolar Soft Part 2 Ovarian Neoplasms 2 Neurofibrosarcoma 2 Malignant mesenchymal tumor 2 Liposarcoma 2 Histiocytoma, Malignant Fibrous 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2 Fibrosarcoma 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Solitary Fibrous Tumors 1 Soft Tissue Neoplasms 1 Sarcoma, Ewing 1 Sarcoma, Endometrial Stromal 1 Rhabdomyosarcoma 1 Recurrent High Grade Meningioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Ichthyosis, X-Linked 1 Gastrointestinal Stromal Tumors 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Extraskeletal Myxoid 1 Central Nervous System Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305548 2026-03-27

ISG-MCS

Italian Sarcoma Group

Phase 2 Recruiting

Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡